×
For best experience we recommend to activate Javascript in your browser.
Cytokeratin 13 antibody (AA 104-403)
This Rabbit Polyclonal antibody specifically detects Cytokeratin 13 in WB, IHC and ELISA. It exhibits reactivity toward Human.
Catalog No. ABIN7569980
$302.55
$355.94
save $53.39 (-15 %)
Plus shipping costs $50.00
Delivery in 12 to 14 Business Days
Quick Overview for Cytokeratin 13 antibody (AA 104-403) (ABIN7569980)
Target
See all Cytokeratin 13 (KRT13) Antibodies
Cytokeratin 13 (KRT13)
(Keratin 13 (KRT13))
Reactivity
All reactivities for Cytokeratin 13 antibodies
Human
Host
All hosts for Cytokeratin 13 antibodies
Rabbit
Clonality
All clonalities for Cytokeratin 13 antibodies
Polyclonal
Conjugate
All conjugates for Cytokeratin 13 antibodies
This Cytokeratin 13 antibody is un-conjugated
Application
All applications for Cytokeratin 13 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), ELISA
Product Details anti-Cytokeratin 13 Antibody
(hide)
Binding Specificity
All epitopes for Cytokeratin 13 antibodies
AA 104-403
Purpose
Anti-KRT13 Polyclonal antibody
Purification
Antigen affinity purification.
Immunogen
E. coli - derived recombinant Human KRT13 (Glu104-Ala403).
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C,-80 °C
Storage Comment
Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
Target Details for Cytokeratin 13
(hide)
Target
Cytokeratin 13 (KRT13)
(Keratin 13 (KRT13))
Alternative Name
KRT13
Background
K13,Keratin,type I cytoskeletal 13,KRT13,Keratin-13,CK-13,Cytokeratin-13
UniProt
P13646
Recently viewed
(hide)
Chat with us , powered by LiveChat